External Advisory Board

NameTitlePerspective
W. Martin Kast, Ph.D.Professor, Molecular Microbiology & Immunology, Obstetrics & Gynecology, and Urology, Director of Medical Biology Graduate Program, Keck School of Medicine of USCHPV vaccines, tumor immunology and HPV human immunological assays
Denise Galloway, Ph.D.Director of Pathogen-Associated Malignancies Integrated Research Center, Fred Hutchinson Cancer Research CenterHPV biology and HPV vaccine development
Mark Einstein, M.D., M.S.Assistant Dean, Rutgers New Jersey Medical SchoolHPV biology, HPV vaccine development, and immunotherapy development for gynecologic cancers
Karan Singh, Ph.D.Professor and Chair, Epidemiology and Biostatistics, The University of Texas Health Science Center at Tyler School of Community and Rural HealthBiostatistics and data management
Ronald Alavarez, M.D., M.B.A.Professor, Obstetrics & Gynecology; Chairman and Clinical Service Chief of Obstetrics & Gynecology, Vanderbilt University Medical CenterClinical trials, gynecologic oncology and pathology
Anita Dallar Walker (UAB)Patient AdvocateRecipient of care at University of Alabama-Birmingham Comprehensive Cancer Center

Internal Advisory Board

NameTitlePerspective
Alison Klein, Ph.D.Professor, Oncology and Pathology, Johns Hopkins University School of MedicinePancreatic cancer, Program Director of GI SPORE
Scott E. Kern, M.D.Professor, Oncology; Co-Director of Gastrointestinal Cancer Program, Johns Hopkins University School of MedicinePancreatic cancer
Elizabeth Jaffee, M.D.Professor, Oncology and Pathology; Associate Director of Bloomberg-Kimmel Institute for Cancer Immunotherapy; Deputy Director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of MedicinePancreatic cancer, immunotherapy development for solid tumors
Louise Chow, Ph.D.Professor, Biochemistry and Molecular Genetics, University of Alabama-Birmingham School of MedicineHPV molecular biology and molecular pathogenesis, cancer biology
Gary L. Rosner, Sc.D.Director of the Quantitative Sciences Program and Biostatistics/Bioinformatics Division, Professor Oncology, Johns Hopkins University School of MedicineBayesian methods, clinical trial methodology, oncology drug development
Rebecca Orzechowski (JHU)Patient AdvocateRecipient of care at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center